New cancer drug trial seeks patients Who've exhausted other options
NCT ID NCT04471987
Summary
This early-stage study is testing the safety and early effectiveness of an experimental drug called IL12-L19L19 in people with advanced solid tumors that have spread. The trial is for patients whose cancer has continued to grow despite receiving standard immunotherapy. Researchers will enroll 80 participants to find the highest safe dose and look for initial signs that the treatment might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Ospedaliero-Universitaria San Luigi Gonzaga
NOT_YET_RECRUITINGOrbassano, Italy
Contact
Contact
-
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, 20133, Italy
Contact
Contact
-
Geneva University Hospital, Oncology Department
RECRUITINGGeneva, Canton of Geneva, 1211, Switzerland
Contact
Contact
-
IEO - Istituto Europeo di Oncologia
RECRUITINGMilan, Italy, Italy
Contact
Contact
-
Insel Gruppe AG
RECRUITINGBern, Canton of Bern, 3010, Switzerland
Contact
Contact
-
Oncology Institute of Southern Switzerland
RECRUITINGBellinzona, 6500, Switzerland
Contact
Contact
-
Universitaetsklinik Hamburg-Eppendorf
RECRUITINGHamburg, Hamburg, Germany
Contact
Contact
-
Universitätsklinikum Heidelberg, Nationalen Centrum für Tumorerkrankungen (NCT), Dermatoonkologie
RECRUITINGHeidelberg, Heidelberg, 69120, Germany
Contact
Contact
-
Universitätsklinikum Leipzig, Klinik für Dermatologie, Venerologie und Allergologie
RECRUITINGLeipzig, Leipzig, 04103, Germany
Contact
Contact
-
Universitätsklinikum Tübingen, Klinik für Innere Medizin VIII Medizinische Onkologie und Pneumologie
RECRUITINGTübingen, 72076, Germany
Contact
Contact
-
Universitätsspital Basel
RECRUITINGBasel, Basel, CH-4031, Switzerland
Contact
Contact
Conditions
Explore the condition pages connected to this study.